- Joined
- Dec 17, 2001
- Messages
- 503
- Reaction score
- 44
Anyone catch the early release article on the NEJM website on CVC vs. PA catheter in Acute Lung Injury? http://content.nejm.org/cgi/reprint/NEJMoa061895v1.pdf
The conclusion is basically that PACs placed within the 1st 48 hrs of ALI (in patients that didn't get one immediately) and which had no reason that they shouldn't be weanable, without CHF or COPD, don't reduce mortality and cause more arrhythmias. This is consistent with retrospective studies and prior smaller randomized studies previously published that were heavily criticized.
It's hard to know what to make of a study that of 11,511 patients screened only managed to enroll 1001. The thing that bothers me the most is that of the screen failures 20.8% were not enrolled because they already had PACs and another 15.9% had the physician decline. It seems like this already pre-selects out all the people who the physicians thought would definitely benefit from a PAC, leaving the trial to figure out whether a PAC was helpful in borderline cases where the physician was already indifferent between a CVC and a PAC.
Also, of note, they did not use mixed venous oxygenation for management relying on PAOP and Cardiac index.
On the other hand, despite my training in using PACs, I would have a hard time finding a good study that supports its use either, beyond my own personal experience in knowing that in some patients I really like knowing the numbers, especially the SvO2. Not necessarily really a good enough reason to put on in, I grant you, but it's what I've got for now.
Any thoughts? Would be interested in what the reaction to this is around the country.
The conclusion is basically that PACs placed within the 1st 48 hrs of ALI (in patients that didn't get one immediately) and which had no reason that they shouldn't be weanable, without CHF or COPD, don't reduce mortality and cause more arrhythmias. This is consistent with retrospective studies and prior smaller randomized studies previously published that were heavily criticized.
It's hard to know what to make of a study that of 11,511 patients screened only managed to enroll 1001. The thing that bothers me the most is that of the screen failures 20.8% were not enrolled because they already had PACs and another 15.9% had the physician decline. It seems like this already pre-selects out all the people who the physicians thought would definitely benefit from a PAC, leaving the trial to figure out whether a PAC was helpful in borderline cases where the physician was already indifferent between a CVC and a PAC.
Also, of note, they did not use mixed venous oxygenation for management relying on PAOP and Cardiac index.
On the other hand, despite my training in using PACs, I would have a hard time finding a good study that supports its use either, beyond my own personal experience in knowing that in some patients I really like knowing the numbers, especially the SvO2. Not necessarily really a good enough reason to put on in, I grant you, but it's what I've got for now.
Any thoughts? Would be interested in what the reaction to this is around the country.